These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2050194)

  • 1. The lack of utility of the rat vas deferens as a functional bioassay for sigma ligands.
    Fox PK; Connick JH; Hanlon GM; France L; Nicholson CD
    Eur J Pharmacol; 1991 Feb; 193(2):139-43. PubMed ID: 2050194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between potentiation of neurogenic twitch contraction and benzomorphan sigma receptor binding potency in the mouse vas deferens.
    Matsuno K; Senda T; Mita S
    Eur J Pharmacol; 1993 Feb; 231(3):451-7. PubMed ID: 8449236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of sigma-receptors in the increase in contraction of mouse vas deferens induced by exogenous ATP.
    Matsuno K; Kobayashi T; Mita S
    J Pharm Pharmacol; 1996 Jan; 48(1):96-9. PubMed ID: 8722504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PCP and sigma ligands on both noradrenaline- and electrically-induced contractions and on [3H]-noradrenaline uptake in rat vas deferens.
    Pubill D; Canudas AM; Sureda FX; Camins A; Pallas M; Escubedo E; Camarasa J
    J Auton Pharmacol; 1998 Aug; 18(4):239-44. PubMed ID: 9788294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guinea-pig vas deferens preparation may contain both receptors and phencyclidine receptors.
    Vaupel DB; Su TP
    Eur J Pharmacol; 1987 Jul; 139(1):125-8. PubMed ID: 2888662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between sigma binding potency and inhibition of contractions in the mouse vas deferens preparation.
    DeHaven-Hudkins DL; Hildebrand LM; Fleissner LC; Ward SJ
    Eur J Pharmacol; 1991 Oct; 203(3):329-35. PubMed ID: 1663452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sigma and phencyclidine receptor ligands on electric field-stimulated rabbit ear artery constriction in vitro.
    Bao WL; Zhen FC; Sun FY; Zhang AZ
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):320-2. PubMed ID: 7801772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar behavioural effects of sigma agonists and PCP-like non-competitive NMDA antagonists in guinea-pigs.
    Brent PJ
    Psychopharmacology (Berl); 1991; 105(3):421-7. PubMed ID: 1686818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations.
    Dumont M; Lemaire S
    Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [3H]desmethylimipramine binding in bovine adrenal medulla: interactions with sigma- and (or) phencyclidine-receptor ligands.
    Rogers C; Lemaire S
    Can J Physiol Pharmacol; 1992 Nov; 70(11):1508-14. PubMed ID: 1338374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites.
    Roman FJ; Pascaud X; Duffy O; Vauche D; Martin B; Junien JL
    Eur J Pharmacol; 1989 Dec; 174(2-3):301-2. PubMed ID: 2560982
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.
    Steinfels GF; Alberici GP; Tam SW; Cook L
    Neuropsychopharmacology; 1988 Dec; 1(4):321-7. PubMed ID: 2855202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guinea pig vas deferens contains sigma but not phencyclidine receptors.
    Su TP; Wu XZ
    Neurosci Lett; 1990 Jan; 108(3):341-5. PubMed ID: 2154729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sigma [corrected] ligand rimcazole antagonises (+)SKF 10,047, but not (+)3-PPP, in the mouse isolated vas deferens.
    Kennedy C; Jarvis GE; Henderson G
    Eur J Pharmacol; 1990 Jun; 181(3):315-8. PubMed ID: 1974518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of sigma and phencyclidine receptor ligands on learning.
    Jones KW; Bauerle LM; DeNoble VJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):97-102. PubMed ID: 2163853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An examination of the putative sigma-receptor in the mouse isolated vas deferens.
    Kennedy C; Henderson G
    Br J Pharmacol; 1989 Oct; 98(2):429-36. PubMed ID: 2555009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures.
    DeCoster MA; Klette KL; Knight ES; Tortella FC
    Brain Res; 1995 Feb; 671(1):45-53. PubMed ID: 7728532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of carbachol-induced inositol phosphate accumulation by phencyclidine, phencyclidine-like ligands and sigma agonists involves blockade of the muscarinic cholinergic receptor: a novel dioxadrol-preferring interaction.
    Brog JS; Beinfeld MC
    J Pharmacol Exp Ther; 1990 Sep; 254(3):952-6. PubMed ID: 2203900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of synapsin I and dynamin in rat forebrain synaptosomes: modulation by sigma (sigma) ligands.
    Brent PJ; Haynes H; Jarvie PE; Mudge L; Sim AT; Dunkley PR
    Neurosci Lett; 1995 May; 191(1-2):71-4. PubMed ID: 7659295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.